C96 is the authoritative medical code for Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue. This classification is used in medical billing and clinical recording to specify the clinical criteria for other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue (ICD-10-CM C96), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: NO. This is a clinician non-billable / parent hierarchy grouping in the ICD-10-CM system.
Sequencing, inclusion, and exclusion notes published for C96 in the official ICD-10-CM tabular list.
Conditions that can never be reported with this code; the two are mutually exclusive.
Conditions not covered by this code, but which may be reported alongside it when both are present.
No. C96 (Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue) is a non-billable ICD-10-CM category code. A more specific billable subcode must be selected based on clinical documentation.
Per official ICD-10-CM Excludes1 instructions, C96 must not be reported together with: personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79).
Per official ICD-10-CM Excludes2 instructions, C96 and the following are not considered part of each other and may both be reported when both conditions are present: Kaposi's sarcoma of lymph nodes (C46.3); secondary and unspecified neoplasm of lymph nodes (C77.-); secondary neoplasm of bone marrow (C79.52); secondary neoplasm of spleen (C78.89).
Official ICD-10-CM classifications closest to C96 in its code family, with their registry titles.